Cargando…
Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss
The functional role of the Hedgehog (Hh)-signaling pathway has been widely investigated in bone physiology/development. Previous studies have, however, focused primarily on Hh functions in bone formation, while its roles in bone resorption have not been fully elucidated. Here, we found that cyclopam...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216259/ https://www.ncbi.nlm.nih.gov/pubmed/32326611 http://dx.doi.org/10.3390/ijms21082745 |
_version_ | 1783532377533841408 |
---|---|
author | Kohara, Yukihiro Haraguchi, Ryuma Kitazawa, Riko Imai, Yuuki Kitazawa, Sohei |
author_facet | Kohara, Yukihiro Haraguchi, Ryuma Kitazawa, Riko Imai, Yuuki Kitazawa, Sohei |
author_sort | Kohara, Yukihiro |
collection | PubMed |
description | The functional role of the Hedgehog (Hh)-signaling pathway has been widely investigated in bone physiology/development. Previous studies have, however, focused primarily on Hh functions in bone formation, while its roles in bone resorption have not been fully elucidated. Here, we found that cyclopamine (smoothened (Smo) inhibitor), GANT-58 (GLI1 inhibitor), or GANT-61 (GLI1/2 inhibitor) significantly inhibited RANKL-induced osteoclast differentiation of bone marrow-derived macrophages. Although the inhibitory effects were exerted by cyclopamine or GANT-61 treatment during 0–48 h (early stage of osteoclast differentiation) or 48–96 h (late stage of osteoclast differentiation) after RANKL stimulation, GANT-58 suppressed osteoclast formation only during the early stage. These results suggest that the Smo-GLI1/2 axis mediates the whole process of osteoclastogenesis and that GLI1 activation is requisite only during early cellular events of osteoclastogenesis. Additionally, macrophage/osteoclast-specific deletion of Smo in mice was found to attenuate the aging phenotype characterized by trabecular low bone mass, suggesting that blockage of the Hh-signaling pathway in the osteoclast lineage plays a protective role against age-related bone loss. Our findings reveal a specific role of the Hh-signaling pathway in bone resorption and highlight that its inhibitors show potential as therapeutic agents that block osteoclast formation in the treatment of senile osteoporosis. |
format | Online Article Text |
id | pubmed-7216259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72162592020-05-22 Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss Kohara, Yukihiro Haraguchi, Ryuma Kitazawa, Riko Imai, Yuuki Kitazawa, Sohei Int J Mol Sci Article The functional role of the Hedgehog (Hh)-signaling pathway has been widely investigated in bone physiology/development. Previous studies have, however, focused primarily on Hh functions in bone formation, while its roles in bone resorption have not been fully elucidated. Here, we found that cyclopamine (smoothened (Smo) inhibitor), GANT-58 (GLI1 inhibitor), or GANT-61 (GLI1/2 inhibitor) significantly inhibited RANKL-induced osteoclast differentiation of bone marrow-derived macrophages. Although the inhibitory effects were exerted by cyclopamine or GANT-61 treatment during 0–48 h (early stage of osteoclast differentiation) or 48–96 h (late stage of osteoclast differentiation) after RANKL stimulation, GANT-58 suppressed osteoclast formation only during the early stage. These results suggest that the Smo-GLI1/2 axis mediates the whole process of osteoclastogenesis and that GLI1 activation is requisite only during early cellular events of osteoclastogenesis. Additionally, macrophage/osteoclast-specific deletion of Smo in mice was found to attenuate the aging phenotype characterized by trabecular low bone mass, suggesting that blockage of the Hh-signaling pathway in the osteoclast lineage plays a protective role against age-related bone loss. Our findings reveal a specific role of the Hh-signaling pathway in bone resorption and highlight that its inhibitors show potential as therapeutic agents that block osteoclast formation in the treatment of senile osteoporosis. MDPI 2020-04-15 /pmc/articles/PMC7216259/ /pubmed/32326611 http://dx.doi.org/10.3390/ijms21082745 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kohara, Yukihiro Haraguchi, Ryuma Kitazawa, Riko Imai, Yuuki Kitazawa, Sohei Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss |
title | Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss |
title_full | Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss |
title_fullStr | Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss |
title_full_unstemmed | Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss |
title_short | Hedgehog Inhibitors Suppress Osteoclastogenesis in In Vitro Cultures, and Deletion of Smo in Macrophage/Osteoclast Lineage Prevents Age-Related Bone Loss |
title_sort | hedgehog inhibitors suppress osteoclastogenesis in in vitro cultures, and deletion of smo in macrophage/osteoclast lineage prevents age-related bone loss |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216259/ https://www.ncbi.nlm.nih.gov/pubmed/32326611 http://dx.doi.org/10.3390/ijms21082745 |
work_keys_str_mv | AT koharayukihiro hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss AT haraguchiryuma hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss AT kitazawariko hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss AT imaiyuuki hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss AT kitazawasohei hedgehoginhibitorssuppressosteoclastogenesisininvitroculturesanddeletionofsmoinmacrophageosteoclastlineagepreventsagerelatedboneloss |